Clinical Trial Update: To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of LuminoMark Injection for nonpalpable breast lesions has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Diseases

Drugs mentioned

• LuminoMark Injection

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Breast Diseases | Phase 2 | Status: COMPLETED